TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03800589

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: phacoemulsification with implantation of the Ex-Press
Description: The conjunctiva is dissected with the base in the limbus. A square scleral flap is dissected with the based in the limbus. Phacoemulsification is performed through a corneal incision 2.75 mm from the temple using the phaco-chop technique. Mini seton was implanted at 12 o'clock according to the standard technique.
Study: NCT04034069

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Robot-assisted training
Description: Fourier M2 upper limb rehabilitation robot (Fourier Intelligence Co. Ltd., Shanghai, China), will be used for upper limb proximal joints training. Fourier M2 upper limb rehab robot is an end-effector robot-assisted device. The device targets (1) flexion and extension of shoulder joint, (2) flexion and extension of elbow, (3) internal and external rotation of shoulder joint, and (4) abduction and adduction of shoulder joint, supported by tailored interactive TV games in the device. HandyRehab hand robot (Zunosaki Company Ltd., Hong Kong SAR) will be used for upper limb distal joints training. It is an exoskeleton over the hand which provides power-driven extension and grasping force to the fingers and thumb in order to assist the patient to open and close the paretic hand by means of surface electromyography-triggered from the signals through the forearm extensors and flexors.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Robot-assisted training
Description: Fourier M2 upper limb rehabilitation robot (Fourier Intelligence Co. Ltd., Shanghai, China), will be used for upper limb proximal joints training. Fourier M2 upper limb rehab robot is an end-effector robot-assisted device. The device targets (1) flexion and extension of shoulder joint, (2) flexion and extension of elbow, (3) internal and external rotation of shoulder joint, and (4) abduction and adduction of shoulder joint, supported by tailored interactive TV games in the device. HandyRehab hand robot (Zunosaki Company Ltd., Hong Kong SAR) will be used for upper limb distal joints training. It is an exoskeleton over the hand which provides power-driven extension and grasping force to the fingers and thumb in order to assist the patient to open and close the paretic hand by means of surface electromyography-triggered from the signals through the forearm extensors and flexors.
Study: NCT04065295

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1356225
Description: Oral Dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1356225
Description: Oral Dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral dose
Study: NCT02582151

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine
Description: Percutaneous patch electrodes are used to deliver low level electrical currents.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine
Description: Percutaneous patch electrodes are used to deliver low level electrical currents.
Study: NCT02316379

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized 129 Xenon
Description: During the scans, subject will inhale hyperpolarized Xenon gas for up to 16 seconds per scan, for up to 4 separate MR scans
Study: NCT00317395

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Otamixaban (XRP0673)
Description: intravenous administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Otamixaban (XRP0673)
Description: intravenous administration
Study: NCT02316379

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI
Study: NCT03008928

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alcooquizz
Study: NCT04957810

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WeChat Mini Program
Description: Through the WeChat applet, it provides services such as visit content configuration, self-image configuration, self-image measurement configuration, and visit reminders.
Study: NCT05022706

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community-based accompaniment and home visits
Description: Trained health promoters will accompany adolescents to their first appointments; facilitate enrollment in public health insurance and completion of other administrative requisites (e.g. obtaining a foreign identification card for migrants; transferring to a different health facility); help troubleshoot new logistical and/or social challenges; and will foster communication between the adult care providers and the patient.~Health promoters will visit the participant's home or another mutually-agreed upon location at least monthly, to review ART adherence, identify barriers to care and adherence, remind patients of upcoming medical encounters, screen and follow-up for clinical and social problems, and offer social support.
Study: NCT04520256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality for Behavioral Weight Loss Skills Training
Description: This program allows participants to practice behavioral weight loss skills using an online virtual reality system accessed via a Web browser.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality for Behavioral Weight Loss Skills Training
Description: This program allows participants to practice behavioral weight loss skills using an online virtual reality system accessed via a Web browser.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality for Behavioral Weight Loss Skills Training
Description: This program allows participants to practice behavioral weight loss skills using an online virtual reality system accessed via a Web browser.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality for Behavioral Weight Loss Skills Training
Description: This program allows participants to practice behavioral weight loss skills using an online virtual reality system accessed via a Web browser.
Study: NCT00317395

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin
Description: intravenous administration
Study: NCT04520256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality for Behavioral Weight Loss Skills Training
Description: This program allows participants to practice behavioral weight loss skills using an online virtual reality system accessed via a Web browser.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Video Feedback
Description: Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.
Study: NCT03800589

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: deep sclerectomy, phacoemulsification, ExPress implantation
Description: The conjunctiva is dissected with the base in the limbus. Superficial flap is dissected with the based in the limbus. Phacoemulsification is performed through a corneal incision 2.75 mm from the temple using the phaco-chop technique. Deep scleral is dissected just below the trabeculo-Descemet membrane. The seton is implanted in the anterior chamber at the height of Schlemm's Canal.
Study: NCT00668018

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levitra (Vardenafil, BAY38-9456)
Description: Vardenafil 10mg orally on demand prior to intercourse
Study: NCT00612014

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 5% dextrose in water
Description: 60 ml IV infusion over 30 minutes

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TZP-101
Description: 40 micrograms/kg iv 2ml/minute for 30 minutes~1 infusion/day for 4 consecutive days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TZP-101
Description: 80 micrograms/kg iv 2ml/minute for 30 minutes~1 infusion/day for 4 consecutive days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TZP-101
Description: 160 micrograms/kg iv 2ml/minute for 30 minutes~1 infusion/day for 4 consecutive days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TZP-101
Description: 320 micrograms/kg iv 2ml/minute for 30 minutes~1 infusion/day for 4 consecutive days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TZP-101
Description: 600 micrograms/kg iv 2ml/minute for 30 minutes~1 infusion/day for 4 consecutive days
Study: NCT02059759

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in this arm will receive sub-cutaneous injections of placebo (same vehicle as for experimental arms, and same volume) for 5 consecutive days at the beginning of three consecutive months (a total of 15 injections, 5 per month for 3 months).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1.0 MIU IL-2 per day
Description: Patients in this arm will receive sub-cutaneous injections corresponding to 1.0 MIU of IL-2 per injection for 5 consecutive days at the beginning of three consecutive months (a total of 15 injections, 5 per month for 3 months).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2.0 MIU IL-2 per day
Description: Patients in this arm will receive sub-cutaneous injections corresponding to 2.0 MIU of IL-2 per injection for 5 consecutive days at the beginning of three consecutive months (a total of 15 injections, 5 per month for 3 months).
Study: NCT02917213

Intervention type: OTHER
Intervention: Doppler echocardiogram exam
Description: A complete echocardiographic study will be performed in the first 24 hours, and after a week and 6 months after enrollment. The echocardiographic images will be acquired as clinically recommended. The protocol will include the acquisition of 1) 2D images in parasternal axis long and short axis; 2) 2D and Doppler tissue images in the apical planes of 4, 2 and 3 chambers; 3) Pulsed, continuous and color Doppler M (DCMM) of transmitral LV flow and LV ejection; 4) 3-Chamber apical plane with and without color Doppler; and 5) 3D LV images. DCMM images will be obtained from the apical window using 4 and 5 chamber planes. Blood flow velocity will be obtained using Color and Gray mode in the 3 chamber view during 5-10 beats in apnea.

Intervention type: OTHER
Intervention: Carotid duplex ultrasound exam
Description: A B-mode and Doppler ultrasound study will be performed using a linear probe 9L (9 MHz) for the evaluation of the common carotid artery bulb, the carotid bifurcation and the internal carotid during 24 h after enrollment. Intima-media thickness will be measured. Turbulent flow velocities in the area of stenosis will be measured by Doppler. The criteria used to grade the severity of carotid atherosclerotic disease will follow the Consensus Conference of the Society of Radiologist in Ultrasound 2003.
Study: NCT05022706

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Directly Observed Therapy
Description: Among adolescents who have already initiated combination antiretroviral therapy (cART), directly observed therapy (DOT) will be provided to the subset of adolescents identified as being at high risk of non-adherence, defined by meeting at least one of the following criteria: 1) identified by the pediatric health provider as having unstable adherence; or 2) having a detectable viral load at one of their two previous measurements. In adolescents newly initiating cART, there will not be an adherence precedent. This group will choose whether they wish to receive DOT. As part of this research, trained community health workers (CHWs) will deliver DOT in participant's homes or in a mutually agreed upon location. CHWs will observe ingestion of cART daily, ensure it is taken as prescribed and record each dose as DOT, self-administered, not taken or not prescribed.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monthly Peer Support Groups
Description: The investigators will assign ALWH to a social support group with 9 to 11 other adolescents also participating in the research. The goal of the social support groups is to provide a venue for participants to share experiences and resources and provide encouragement and support to one another. Each group will last approximately 3 to 4 hours. Support groups will be led by adult peers or trained community health workers. The final group session will incorporate a discussion about the group experience, how it may change behavior, recommendations for improvement, and unmet needs that should be considered for a future intervention.
Study: NCT04050228

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound to guide adaptive chemotherapy
Description: Quantitative ultrasound results will be used to measure chemotherapy response and guide an adaptive chemotherapy strategy for patients who are found to be nonresponders to their chemotherapy.
Study: NCT02995811

Intervention type: OTHER
Intervention: Observational Cohort
Description: Ultrasound assessment of 4 muscles, activity monitoring, daily global peripheral skeletal muscle strength
Study: NCT02563886

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrically Assisted Movement Therapy
Description: Electrically Assisted Movement Therapy (EAMT) is an extension of conventional Constraint-Induced Movement Therapy (CIMT) for moderately-to-severely paralyzed patients. During EAMT, patients use a movement controller with the healthy hand, controlling movements generated through neuromuscular electrical stimulation of the paralyzed arm and hand. During each session three types of exercises can be performed: mobilization, games, and training for activities of daily living, all three involving proper shaping of exercise difficulty at therapist discretion. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electrically Assisted Movement Therapy
Description: Electrically Assisted Movement Therapy (EAMT) is an extension of conventional Constraint-Induced Movement Therapy (CIMT) for moderately-to-severely paralyzed patients. During EAMT, patients use a movement controller with the healthy hand, controlling movements generated through neuromuscular electrical stimulation of the paralyzed arm and hand. During each session three types of exercises can be performed: mobilization, games, and training for activities of daily living, all three involving proper shaping of exercise difficulty at therapist discretion. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual and customary care
Description: Usual and customary care ranges from no treatment to varying amounts of orthotics, home-based and clinic-based occupational therapy, or physiotherapy, but always excludes CIMT and EAMT. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks, whenever possible, to match EAMT amount of therapy.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual and customary care
Description: Usual and customary care ranges from no treatment to varying amounts of orthotics, home-based and clinic-based occupational therapy, or physiotherapy, but always excludes CIMT and EAMT. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks, whenever possible, to match EAMT amount of therapy.
Study: NCT03035058

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Description: Vedolizumab intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Description: Vedolizumab intravenous infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study: NCT02633917

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor control exercises
Description: exercises to strength the lumbar musculature and control the posture

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard exercises
Description: general exercises
Study: NCT04671745

Intervention type: BEHAVIORAL
Intervention: Music
Description: patient receiving care with interactive music

Intervention type: BEHAVIORAL
Intervention: No music
Description: patient receiving care without interactive music
Study: NCT03797794

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsating Electrostatic Field
Description: A pulsating electrostatic field is generated by the New Health 9000 (Akern). During the session the patients sits on a chair which contains the apparatus for 30 minutes.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM Pulsating Electrostatic Field
Description: The same apparatus which produces the pulsating electrostatic field contains a 'sham-inlet'. This inlet will be used as placebo.
Study: NCT00317395

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: eptifibatide
Description: intravenous administration
Study: NCT02788994

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endovis BA2 nail
Description: The EBA2 intramedullary nailing system is designed for the treatment of lateral proximal femoral fractures, and consists of a standard or medium length nail implantable with the same set of instruments.~The system has been designed to allow:~* stable fracture synthesis for fast rehabilitation and early mobilization~* an efficient set of instruments (only 11) for a swift, reproducible operating technique (just 7 surgical steps)
Study: NCT04890730

Intervention type: OTHER
Intervention: Esophagogastroduodenoscopies
Description: Each enrolled patient needs to undergo Esophagogastroduodenoscopies and elastography
Study: NCT00842712

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: Cetuximab will be administered at a dose of 400 mg/m\^2 as intravenous infusion over 2 hours on Day 1 of Cycle 1 followed by 250 mg/m\^2 intravenous infusion over 1 hour once weekly on Days 8 and 15 of Cycle 1 and Days 1, 8, and 15 of all subsequent cycles until progressive disease, death, unacceptable toxicity, or consent withdrawal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Cetuximab will be administered at a dose of 400 mg/m\^2 as intravenous infusion over 2 hours on Day 1 of Cycle 1 followed by 250 mg/m\^2 intravenous infusion over 1 hour once weekly on Days 8 and 15 of Cycle 1 and Days 1, 8, and 15 of all subsequent cycles until progressive disease, death, unacceptable toxicity, or consent withdrawal.
Study: NCT04890730

Intervention type: OTHER
Intervention: Esophagogastroduodenoscopies
Description: Each enrolled patient needs to undergo Esophagogastroduodenoscopies and elastography

Intervention type: OTHER
Intervention: Esophagogastroduodenoscopies
Description: Each enrolled patient needs to undergo Esophagogastroduodenoscopies and elastography
Study: NCT02788994

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Description: The DHS is designed to provide strong and stable internal fixation of a variety of intertrochanteric, subtrochanteric and basilar neck fractures, with minimal soft tissue irritation.~This Dynamic Hip Screw method is currently used and is a one off surgical fixation.
Study: NCT01554267

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser-Assisted ICG Dye Angiography (SPY System)
Description: 7.5-10mg of ICG dye will be injected at 2 different time points during breast reconstruction with the assistance of the SPY system to determine areas of skin with poor blood flow. These areas are excised during the operation in order to decrease postoperative complications including mastectomy skin flap necrosis and reconstruction failure.
Study: NCT01275859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole, Lapatinib
Description: Letrozole 2.5mg po qd+ Lapatinib 1500mg po qd for 18-21 wks
Study: NCT04503473

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Stepping Training
Description: The goals will be to maximize stepping activity at high intensities for 40 minutes per 1 hour session, with rest breaks as needed~Conventional Therapy: : Participants provided conventional therapy will perform various standardized exercise tasks during 40 minutes of 1 hr sessions

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: Participants provided conventional therapy will perform various standardized exercise tasks during 40 minutes of 1 hr sessions
Study: NCT01894685

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesalazine
Description: Mesalazine 3 grams, once daily for six months

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 3 grams, once daily for six months
Study: NCT01951326

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RHB-104
Description: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine